483
XCATH INCXCATH INC – FDA 483, Oct 26, 2021
Record Details
An FDA inspection of XCATH INC in Houston, TX, a medical device manufacturer, revealed significant deficiencies in its design control processes. The firm failed to adequately verify design outputs against inputs, did not properly translate device designs into production specifications, and lacked established procedures for comprehensive design reviews, particularly involving all contract manufacturers. These issues indicate a breakdown in the quality system for the (b)(4) Guidewire System.
View Company Profile
ID · 003e7dca-71c6-444c-bc6e-cf1e75aff4a1
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.